Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß1−42, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment

Emmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, Audrey Gabelle, Sylvain Lehmann, Florence Pasquier, Stéphanie Bombois, Luc Buée, Bernadette Allinquant, Susanna Schraen-Maschke, Christiane Baret, Anne-Sophie Rigaud, Olivier Hanon, Jacques Epelbaum

Open source

DOI: 10.3389/fnagi.2019.00011
Published: 2019-02-19
Container: Frontiers in Aging Neuroscience
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fnagi.2019.00011,
  title = {Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß1−42, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment},
  author = {Emmanuelle Duron and Jean-Sébastien Vidal and Dominique Grousselle and Audrey Gabelle and Sylvain Lehmann and Florence Pasquier and Stéphanie Bombois and Luc Buée and Bernadette Allinquant and Susanna Schraen-Maschke and Christiane Baret and Anne-Sophie Rigaud and Olivier Hanon and Jacques Epelbaum},
  year = {2019},
  journal = {Frontiers in Aging Neuroscience},
  doi = {10.3389/fnagi.2019.00011},
  url = {https://doi.org/10.3389/fnagi.2019.00011}
}

RIS

TY  - JOUR
TI  - Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß1−42, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
AU  - Emmanuelle Duron
AU  - Jean-Sébastien Vidal
AU  - Dominique Grousselle
AU  - Audrey Gabelle
AU  - Sylvain Lehmann
AU  - Florence Pasquier
AU  - Stéphanie Bombois
AU  - Luc Buée
AU  - Bernadette Allinquant
AU  - Susanna Schraen-Maschke
AU  - Christiane Baret
AU  - Anne-Sophie Rigaud
AU  - Olivier Hanon
AU  - Jacques Epelbaum
PY  - 2019
JO  - Frontiers in Aging Neuroscience
DO  - 10.3389/fnagi.2019.00011
UR  - https://doi.org/10.3389/fnagi.2019.00011
ER  -

APA

Duron, E., Vidal, J., Grousselle, D., Gabelle, A., Lehmann, S., Pasquier, F., Bombois, S., Buée, L., Allinquant, B., Schraen-Maschke, S., Baret, C., Rigaud, A., Hanon, O., & Epelbaum, J. (2019). Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß1−42, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2019.00011

Source records

crossref · retrieved 2026-09-26T11:28:50.820Z